Prodigy Gold NL News - PRX

Par Pharmaceutical Companies to Report Fourth Quarter and Full Year 2009 Results on February 24, 2010

WOODCLIFF LAKE, N.J., Feb. 2 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) announced today that it will host a...

MonoSol Rx and Strativa Pharmaceuticals Extend Strategic Relationship

Option to collaborate on three new products Relationship built on successful development of ondansetron oral soluble film currently under FDA...

Par Pharmaceutical Receives Final Approval to Market Generic Ultram(R) ER

Par to Begin Shipping Tramadol ER Immediately WOODCLIFF LAKE, N.J., Nov. 16 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc...

Par Pharmaceutical Reports EPS of $0.76 for Third Quarter 2009

Achieves Record Quarterly Gross Margin of $92 Million WOODCLIFF LAKE, N.J., Nov. 6 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc...

AstraZeneca Asks Court To Rule Quickly In Crestor Patent Row

AstraZeneca PLC (AZN) has asked a U.S. court for an early ruling on a patent dispute over the U.K. company's blockbuster statin Crestor which is...

Par Pharmaceutical Receives Final Approval To Market Generic Starlix(R)

Par to Begin Shipping Nateglinide Immediately WOODCLIFF LAKE, N.J., Sept. 10 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc...

Par Pharmaceutical Reports EPS of $0.71 for Second Quarter 2009

Brand & Generic Business Units Drive Strong Earnings WOODCLIFF LAKE, N.J., Aug. 4 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc...

UPDATE: Watson Pharma 2Q Net Down 12%; Toprol Seen Boosting Fiscal Year

Watson Pharmaceuticals Inc. (WPI) reported a 12% drop in second-quarter earnings, due to items, but raised its 2009 financial expectations citing...

Par Pharmaceutical to Host Second Quarter 2009 Earnings Conference Call on August 4 at 9:00 am

WOODCLIFF LAKE, N.J., July 15 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) announced today that it will host a...

UPDATE:DOJ Changes Policy On Pharma Pacts That Delay Generics

The U.S. Department of Justice on Monday took a skeptical view on the legality of pharmaceutical patent settlements that delay the introduction of...

DOJ Changes Policy On Pharma Settlements That Delay Generics

The U.S. Department of Justice on Monday took a skeptical view on the legality of pharmaceutical patent settlements that delay the introduction of...

UPDATE: Lawmakers, Drug Makers Spar Over Patent Settlements

Executives for Mylan Inc. (MYL) and Endo Pharmaceuticals Inc. (ENDP) faced a grilling on Capitol Hill Wednesday from lawmakers who support...

Lawmakers, Drug Makers Spar Over Pharma Patent Settlements

Executives for Mylan Inc. (MYL) and Endo Pharmaceuticals Inc. (ENDP) faced a grilling on Capitol Hill Wednesday from lawmakers who support...

AstraZeneca Lifts Toprol Sales Limits; Benefits From Shortage

AstraZeneca Plc (AZN) has lifted allocation limits for blood-pressure medicine Toprol XL that were put in place to ensure supply of the drug after...

MonoSol Rx and Strativa Pharmaceuticals Submit New Drug Application for Ondansetron Orally Dissolving Film Strip

WARREN, N.J., April 9 /PRNewswire/ -- MonoSol Rx, the developers of PharmFilm(R) technology and a drug delivery company specializing in...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Prodigy Gold NL (PRX)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

PRX News

Par Pharmaceutical Companies to Report Fourth Quarter and Full Year 2009 Results on February 24, 2010

MonoSol Rx and Strativa Pharmaceuticals Extend Strategic Relationship

Par Pharmaceutical Receives Final Approval to Market Generic Ultram(R) ER

Par Pharmaceutical Reports EPS of $0.76 for Third Quarter 2009

AstraZeneca Asks Court To Rule Quickly In Crestor Patent Row

Par Pharmaceutical Receives Final Approval To Market Generic Starlix(R)

Par Pharmaceutical Reports EPS of $0.71 for Second Quarter 2009

UPDATE: Watson Pharma 2Q Net Down 12%; Toprol Seen Boosting Fiscal Year

Par Pharmaceutical to Host Second Quarter 2009 Earnings Conference Call on August 4 at 9:00 am

UPDATE:DOJ Changes Policy On Pharma Pacts That Delay Generics

DOJ Changes Policy On Pharma Settlements That Delay Generics

UPDATE: Lawmakers, Drug Makers Spar Over Patent Settlements

Lawmakers, Drug Makers Spar Over Pharma Patent Settlements

AstraZeneca Lifts Toprol Sales Limits; Benefits From Shortage

MonoSol Rx and Strativa Pharmaceuticals Submit New Drug Application for Ondansetron Orally Dissolving Film Strip

PRX Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Prodigy Gold NL (PRX) News

Prodigy Gold NL (PRX)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

PRX News

Par Pharmaceutical Companies to Report Fourth Quarter and Full Year 2009 Results on February 24, 2010

MonoSol Rx and Strativa Pharmaceuticals Extend Strategic Relationship

Par Pharmaceutical Receives Final Approval to Market Generic Ultram(R) ER

Par Pharmaceutical Reports EPS of $0.76 for Third Quarter 2009

AstraZeneca Asks Court To Rule Quickly In Crestor Patent Row

Par Pharmaceutical Receives Final Approval To Market Generic Starlix(R)

Par Pharmaceutical Reports EPS of $0.71 for Second Quarter 2009

UPDATE: Watson Pharma 2Q Net Down 12%; Toprol Seen Boosting Fiscal Year

Par Pharmaceutical to Host Second Quarter 2009 Earnings Conference Call on August 4 at 9:00 am

UPDATE:DOJ Changes Policy On Pharma Pacts That Delay Generics

DOJ Changes Policy On Pharma Settlements That Delay Generics

UPDATE: Lawmakers, Drug Makers Spar Over Patent Settlements

Lawmakers, Drug Makers Spar Over Pharma Patent Settlements

AstraZeneca Lifts Toprol Sales Limits; Benefits From Shortage

MonoSol Rx and Strativa Pharmaceuticals Submit New Drug Application for Ondansetron Orally Dissolving Film Strip

PRX Discussion

Your Recent History